Parthasarathy Gopanandan, Chen Jun, Chen Xianfeng, Chia Nicholas, O'Connor Helen M, Wolf Patricia G, Gaskins H Rex, Bharucha Adil E
Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota.
Gastroenterology. 2016 Feb;150(2):367-79.e1. doi: 10.1053/j.gastro.2015.10.005. Epub 2015 Oct 13.
BACKGROUND & AIMS: In fecal samples from patients with chronic constipation, the microbiota differs from that of healthy subjects. However, the profiles of fecal microbiota only partially replicate those of the mucosal microbiota. It is not clear whether these differences are caused by variations in diet or colonic transit, or are associated with methane production (measured by breath tests). We compared the colonic mucosal and fecal microbiota in patients with chronic constipation and in healthy subjects to investigate the relationships between microbiota and other parameters.
Sigmoid colonic mucosal and fecal microbiota samples were collected from 25 healthy women (controls) and 25 women with chronic constipation and evaluated by 16S ribosomal RNA gene sequencing (average, 49,186 reads/sample). We assessed associations between microbiota (overall composition and operational taxonomic units) and demographic variables, diet, constipation status, colonic transit, and methane production (measured in breath samples after oral lactulose intake).
Fourteen patients with chronic constipation had slow colonic transit. The profile of the colonic mucosal microbiota differed between constipated patients and controls (P < .05). The overall composition of the colonic mucosal microbiota was associated with constipation, independent of colonic transit (P < .05), and discriminated between patients with constipation and controls with 94% accuracy. Genera from Bacteroidetes were more abundant in the colonic mucosal microbiota of patients with constipation. The profile of the fecal microbiota was associated with colonic transit before adjusting for constipation, age, body mass index, and diet; genera from Firmicutes (Faecalibacterium, Lactococcus, and Roseburia) correlated with faster colonic transit. Methane production was associated with the composition of the fecal microbiota, but not with constipation or colonic transit.
After adjusting for diet and colonic transit, the profile of the microbiota in the colonic mucosa could discriminate patients with constipation from healthy individuals. The profile of the fecal microbiota was associated with colonic transit and methane production (measured in breath), but not constipation.
在慢性便秘患者的粪便样本中,微生物群与健康受试者不同。然而,粪便微生物群的特征仅部分复制了黏膜微生物群的特征。尚不清楚这些差异是由饮食或结肠转运的变化引起的,还是与甲烷产生(通过呼气试验测量)有关。我们比较了慢性便秘患者和健康受试者的结肠黏膜和粪便微生物群,以研究微生物群与其他参数之间的关系。
从25名健康女性(对照组)和25名慢性便秘女性中收集乙状结肠黏膜和粪便微生物群样本,并通过16S核糖体RNA基因测序进行评估(平均每个样本49186条读数)。我们评估了微生物群(总体组成和操作分类单元)与人口统计学变量、饮食、便秘状态、结肠转运和甲烷产生(口服乳果糖后在呼气样本中测量)之间的关联。
14名慢性便秘患者结肠转运缓慢。便秘患者和对照组的结肠黏膜微生物群特征不同(P < 0.05)。结肠黏膜微生物群的总体组成与便秘相关,独立于结肠转运(P < 0.05),并以94%的准确率区分便秘患者和对照组。拟杆菌属在便秘患者的结肠黏膜微生物群中更为丰富。在调整便秘、年龄、体重指数和饮食之前,粪便微生物群的特征与结肠转运相关;厚壁菌门(粪杆菌属、乳球菌属和罗氏菌属)的属与更快的结肠转运相关。甲烷产生与粪便微生物群的组成相关,但与便秘或结肠转运无关。
在调整饮食和结肠转运后,结肠黏膜中微生物群的特征可以区分便秘患者和健康个体。粪便微生物群的特征与结肠转运和甲烷产生(在呼气中测量)相关,但与便秘无关。